DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA damage induces STING mediated IL-6-STAT3 survival pathway in triple-negative breast cancer cells and decreased survival of breast cancer patients
Authors
Keywords
-
Journal
APOPTOSIS
Volume 27, Issue 11-12, Pages 961-978
Publisher
Springer Science and Business Media LLC
Online
2022-08-26
DOI
10.1007/s10495-022-01763-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pancancer survival analysis of cancer hallmark genes
- (2021) Ádám Nagy et al. Scientific Reports
- Tumor microenvironment differences between primary tumor and brain metastases
- (2020) Bernardo Cacho-Díaz et al. Journal of Translational Medicine
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- cGAS-STING pathway in oncogenesis and cancer therapeutics
- (2020) Brandon Yi Da Hoong et al. Oncotarget
- Targeting STAT3 in Cancer Immunotherapy
- (2020) Sailan Zou et al. Molecular Cancer
- DNA Damage and Cancer Immunotherapy: A STING in the Tale
- (2020) Timo Reisländer et al. MOLECULAR CELL
- STAT3 inhibition enhances CDN-induced STING signaling and antitumor immunity
- (2019) Jianwen Pei et al. CANCER LETTERS
- STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
- (2019) Zerdes et al. Cancers
- Unraveling triple-negative breast cancer tumor microenvironment heterogeneity: towards an optimized treatment approach
- (2019) Yacine Bareche et al. JNCI-Journal of the National Cancer Institute
- Cytokines in the Treatment of Cancer
- (2018) Kevin C. Conlon et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Chromosomal instability drives metastasis through a cytosolic DNA response
- (2018) Samuel F. Bakhoum et al. NATURE
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- Role of the NFκB-signaling pathway in cancer
- (2018) Longzheng Xia et al. OncoTargets and Therapy
- Non-canonical Activation of the DNA Sensing Adaptor STING by ATM and IFI16 Mediates NF-κB Signaling after Nuclear DNA Damage
- (2018) Gillian Dunphy et al. MOLECULAR CELL
- Roles of the immune system in cancer: from tumor initiation to metastatic progression
- (2018) Hugo Gonzalez et al. GENES & DEVELOPMENT
- Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression?
- (2018) Lucía Angélica Méndez-García et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer
- (2018) Xiaoxia Jiang et al. Cancer Management and Research
- STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC
- (2017) L.L. Bu et al. JOURNAL OF DENTAL RESEARCH
- PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
- (2017) Vikram R. Juneja et al. JOURNAL OF EXPERIMENTAL MEDICINE
- cGAS surveillance of micronuclei links genome instability to innate immunity
- (2017) Karen J. Mackenzie et al. NATURE
- DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells
- (2017) Hiro Sato et al. Nature Communications
- Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
- (2016) Shilpi Saha et al. CANCER RESEARCH
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
- (2016) Eileen E. Parkes et al. JNCI-Journal of the National Cancer Institute
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- Antiviral signaling protein MITA acts as a tumor suppressor in breast cancer by regulating NF-κB induced cell death
- (2013) Khyati Bhatelia et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Genome engineering using the CRISPR-Cas9 system
- (2013) F Ann Ran et al. Nature Protocols
- NF-κB-Induced IL-6 Ensures STAT3 Activation and Tumor Aggressiveness in Glioblastoma
- (2013) Braden C. McFarland et al. PLoS One
- Nucleo-Cytoplasmic Trafficking of TRIM8, a Novel Oncogene, Is Involved in Positive Regulation of TNF Induced NF-κB Pathway
- (2012) Dhanendra Tomar et al. PLoS One
- TRIM13 regulates ER stress induced autophagy and clonogenic ability of the cells
- (2011) Dhanendra Tomar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients
- (2011) Praveen Ravishankaran et al. World Journal of Surgical Oncology
- Immune surveillance: a balance between protumor and antitumor immunity
- (2008) Suzanne Ostrand-Rosenberg CURRENT OPINION IN GENETICS & DEVELOPMENT
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started